← brief for 2026-09-28 · Slowing decline

Risk factors for recurrent urinary tract infection after SGLT2 inhibitor reinitiation in type 2 diabetes.

Article C Peer reviewed Observational

Key takeaways

This study looked at 316 people with type 2 diabetes who restarted SGLT2 drugs after a urinary tract infection. It found that some patients had a higher chance of getting another infection. The study shows a link between certain health factors and infection risk, but it does not prove cause and effect. This helps doctors decide who is safe to restart these kidney-protecting drugs.

Who did this work

Hsueh YC · Lin CH · Liu PH · Lin YH

Source

Article · PubMed, the drug frontier · 2026 Sep 28
https://pubmed.ncbi.nlm.nih.gov/42803855/